Comparision of various parameters between control and experimental groups at 1, 2, 3, 4, 5, 6 months
Parameter | 1 month | 2 months | 3 months | 4 months | 5 months | 6 months | ||||||
Control | Experimental | Control | Experimental | Control | Experimental | Control | Experimental | Control | Experimental | Control | Experimental | |
Bcl-2 | 1.059 ±0.593 | 1.139 ±0.404 | 1.009 ±0.712 | 27.769 ±5.651 | 1.530 ±0.479 | 32.630 ±3.138 | 1.843 ±0.368 | 33.777 ±4.221 | 2.056 ±0.593 | 45.024 ±4.002 | 2.247 ±0.374 | 51.150 ±3.951 |
F
(P) | 0.124 0.729 | 220.739 <0.001 | 959.975 <0.001 | 568.022 <0.001 | 1127.729 <0.001 | 1518.235 <0.001 | ||||||
PCNA | 11.314 ±4.500 | 15.064 ±4.022 | 9.011 ±4.393 | 17.484 ±3.533 | 16.641 ±2.653 | 23.121 ±1.764 | 7.276 ±3.562 | 32.318 ±3.954 | 10.435 ±4.077 | 48.328 ±4.163 | 9.347 ±2.771 | 55.007 ±6.958 |
F
(P) | 3.862 0.065 | 22.588 <0.001 | 41.368 <0.001 | 221.458 <0.001 | 422.850 <0.001 | 371.639 <0.001 | ||||||
Cyclin- D1 | 0.761 ±0.327 | 0.961 ±0.291 | 0.603 ±0.095 | 1.516 ±0.417 | 0.804 ±0.153 | 1.981 ±0.355 | 0.808 ±0.252 | 2.633 ±0.423 | 0.781 ±0.140 | 3.001 ±0.571 | 0.836 ±0.212 | 4.663 ±0.479 |
F
(P) | 2.094 0.165 | 45.628 <0.001 | 92.905 <0.001 | 137.258 <0.001 | 142.577 <0.001 | 533.179 <0.001 | ||||||
TUNEL | 8.875 ±2.737 | 11.430 ±2.954 | 14.253 ±3.776 | 20.639 ±3.200 | 16.616 ±4.541 | 31.065 ±4.387 | 16.633 ±2.696 | 42.085 ±5.718 | 14.845 ±3.525 | 58.814 ±5.432 | 17.488 ±3.897 | 71.893 ±4.244 |
F
(P) | 4.026 0.060 | 16.648 0.001 | 52.372 <0.001 | 162.088 <0.001 | 461.067 <0.001 | 891.412 <0.001 |
Data are mean±SD.
Bcl-2, B cell lymphoma-2; PCNA, proliferating cell nuclear antigen; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling.